New eye drops could help kids see clearly longer

NCT ID NCT06579287

Ongoing Disease control Sponsor: Sunhawk Vision Biotech, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new eye drop called SHJ002 to see if it can safely slow down worsening nearsightedness (myopia) in children ages 3 to 12. The drop works by targeting a specific molecule in the eye. Researchers will compare it to a standard treatment, atropine, and measure changes in vision and eye length over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOPIA, PROGRESSIVE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

degenerative myopia myopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MYOPIA, PROGRESSIVE

Contacts and locations

Locations

Cathay General Hospital

Taipei, 106, Taiwan
Chang Cung Memorial Hospital-Tucheng

New Taipei City, 236, Taiwan
Changhua Christian Hospital

Chang-hua, Taiwan
Chung Shan Medical University Hospital

Taichung, 402, Taiwan
Kaohsiung Veterans General Hospital

Kaohsiung City, 813, Taiwan
MacKay Memorial Hospital-Tamsui

New Taipei City, 251, Taiwan
Pacific Center for Advanced Vision Care Tanasbourne Vision Center

Hillsboro, Ohio, 97124, United States
Taipei Veterans General Hospital

Taipei, 201, Taiwan
Tri-Service General Hospital

Taipei, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.